BioRem Statistics

Total Valuation

BioRem has a market cap or net worth of CAD 36.11 million. The enterprise value is 32.56 million.

Market Cap	36.11M
Enterprise Value	32.56M

Important Dates

The next estimated earnings date is Friday, April 4, 2025.

Earnings Date	Apr 4, 2025
Ex-Dividend Date	n/a

Share Statistics

BioRem has 16.12 million shares outstanding. The number of shares has decreased by -0.27% in one year.

Current Share Class	n/a
Shares Outstanding	16.12M
Shares Change (YoY)	-0.27%
Shares Change (QoQ)	+0.63%
Owned by Insiders (%)	1.94%
Owned by Institutions (%)	n/a
Float	15.81M

Valuation Ratios

The trailing PE ratio is 7.61.

PE Ratio	7.61
Forward PE	n/a
PS Ratio	0.88
PB Ratio	3.56
P/TBV Ratio	3.63
P/FCF Ratio	6.99
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.28, with an EV/FCF ratio of 6.30.

EV / Earnings	6.26
EV / Sales	0.81
EV / EBITDA	4.28
EV / EBIT	4.60
EV / FCF	6.30

Financial Position

The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.37.

Current Ratio	1.91
Quick Ratio	1.50
Debt / Equity	0.37
Debt / EBITDA	0.49
Debt / FCF	0.72
Interest Coverage	29.90

Financial Efficiency

Return on equity (ROE) is 71.98% and return on invested capital (ROIC) is 40.80%.

Return on Equity (ROE)	71.98%
Return on Assets (ROA)	21.09%
Return on Invested Capital (ROIC)	40.80%
Return on Capital Employed (ROCE)	54.69%
Revenue Per Employee	1.19M
Profits Per Employee	152,927
Employee Count	34
Asset Turnover	1.92
Inventory Turnover	12.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +51.68% in the last 52 weeks. The beta is 0.84, so BioRem's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	+51.68%
50-Day Moving Average	2.62
200-Day Moving Average	2.55
Relative Strength Index (RSI)	35.51
Average Volume (20 Days)	36,522

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioRem had revenue of CAD 40.31 million and earned 5.20 million in profits. Earnings per share was 0.29.

Revenue	40.31M
Gross Profit	12.87M
Operating Income	7.09M
Pretax Income	6.90M
Net Income	5.20M
EBITDA	7.43M
EBIT	7.09M
Earnings Per Share (EPS)	0.29

Full Income Statement

Balance Sheet

The company has 7.27 million in cash and 3.73 million in debt, giving a net cash position of 3.54 million or 0.22 per share.

Cash & Cash Equivalents	7.27M
Total Debt	3.73M
Net Cash	3.54M
Net Cash Per Share	0.22
Equity (Book Value)	9.96M
Book Value Per Share	0.63
Working Capital	10.44M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.41 million and capital expenditures -246,142, giving a free cash flow of 5.17 million.

Operating Cash Flow	5.41M
Capital Expenditures	-246,142
Free Cash Flow	5.17M
FCF Per Share	0.32

Full Cash Flow Statement

Margins

Gross margin is 31.92%, with operating and profit margins of 17.58% and 12.90%.

Gross Margin	31.92%
Operating Margin	17.58%
Pretax Margin	17.11%
Profit Margin	12.90%
EBITDA Margin	18.42%
EBIT Margin	17.58%
FCF Margin	12.82%

Dividends & Yields

BioRem does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.27%
Shareholder Yield	0.27%
Earnings Yield	14.40%
FCF Yield	14.31%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioRem has an Altman Z-Score of 4.3.

Altman Z-Score	4.3
Piotroski F-Score	n/a